Bioavailability / Bioequivalence / Biosimilars Clinical Trials

Generic drugs. Custom solutions.

Increasing demand for generic pharmaceutical products and intensifying pressure to be the first-to-market are driving shorter timelines. inVentiv Health Clinical can help.

Our significant experience in conducting a full range of bioavailability/bioequivalence drug clinical trialshas given us a complete understanding of the generic development process, so you can have confidence that your project will be completed professionally and on time. Our large capacity means that we can be ready when you are, including the assessment of performance in special populations. Our generic drug development services include protocol development, conduct of the clinical study, clinical laboratory, pharmacokinetics, and medical writing.

If you are developing follow-on biologicals or biosimilars, opportunities are increasing despite the unique complexity of demonstrating similarity of efficacy and safety and the evolving regulatory landscape. For more information on latest offerings to assist you with the development of biosimilars, click here.

Phase I-IIa Brochure